David Winpenny

 David Winpenny
David Winpenny
Principal Scientist
Pfizer Neusentis

Presentations at Drug Discovery 2015

Wed2  Sep11:00am(30 mins)
Biased Ligand Quantification in Drug Discovery: From Theory to High Throughput Screening to Identify New Biased ยต Opioid Receptor Agonists

Session: Innovation in Assay Development & Screening
Room: To be announced

Profile of David Winpenny

David Winpenny is a Principal Scientist at Pfizer Neusentis in Cambridge UK. He has over 20 years experience within assay development, screening and data analysis across a range of target classes including GPCRS, RTKs, transporters and ion channels.
Please login to send a Private Message

Hosted By
The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Event Logo Find us on Facebook Follow us on Twitter

Get the App
Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
iPhone App
Android App
Eventflo Home
copyright ELRIG, eventflo, Labhoo Ltd 2018